India's Dr. Reddy's, Australia's Alphapharm Ruled Violating U.S. Patents
This article was originally published in PharmAsia News
Executive Summary
Indian and Australian makers of generic drugs were among three firms declared by a U.S. judge to have violated the patents of Pozen, U.S. maker of Treximent (sumatiptan/naproxen) for migraine headaches